Production of two Excedrin painkillers halted

Production and distribution of Excedrin Extra Strength and Excedrin Migraine products have been temporarily stopped, maker GlaxoSmithKline said Tuesday.

“Through routine quality control and assurance measures, we discovered inconsistencies in how we transfer and weigh ingredients for Excedrin Extra Strength Caplets and Geltabs, and Excedrin Migraine Caplets and Geltabs,” the company said in a statement to CNN.

“We are working hard to resolve the issue as quickly as possible, but at this point in time cannot confirm a definite date as to when supply will resume,” the company said.

Source: Read Full Article

Related posts:
  1. QUARTER of GP surgeries take two years to start prescribing new drugs
  2. Two more UK companies recall their versions of Zantac heartburn drug
  3. Happiness High in States With Lots of Parks, Libraries
  4. Children shape their learning environment—the case of language acquisition in children with ASD
  5. Where you die can affect your chance of being an organ donor